Keyphrases
Peroxisome Proliferator-activated Receptor
100%
Isoform Selectivity
100%
Chemotype
100%
Benzyloxy
100%
Retinal Disorders
100%
Alpha Agonist
100%
Vascular Leakage
33%
Inflammation
16%
Preclinical Evaluation
16%
Endothelial Cells
16%
Neurodegeneration
16%
Pharmacokinetics-pharmacodynamics (PK-PD)
16%
Related Compounds
16%
Diabetic Retinopathy
16%
Age-related Macular Degeneration
16%
In Vivo Efficacy
16%
Retinal Diseases
16%
Genetic Tools
16%
Drug Target
16%
Retinal pigment Epithelium
16%
Agonism
16%
Streptozotocin-induced
16%
Promising Drug
16%
Neovascularization
16%
Leakage Model
16%
Pharmacokinetic Evaluation
16%
Pharmacological Tools
16%
α Isoform
16%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor Alpha
100%
Peroxisome Proliferator Activated Receptor Alpha Agonist
100%
Clinical Trial
20%
Rat Model
20%
Streptozotocin
20%
Retina Disease
20%
Age Related Macular Degeneration
20%
Neovascularization (Pathology)
20%
Visual Pigment
20%
Nerve Degeneration
20%
Diabetic Retinopathy
20%
Vasculitis
20%
Pharmacokinetics
20%